Immunocore Holdings plc American Depositary Shares (IMCR) Stock Price

IMCRStock

$29.40−12.32%52W

Market Cap$1.51B

P/E—

PEG Ratio—

Div yield—

Beta0.82

IMCR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-17.13%

Price vs S&P 500 (4W)-7.31%

VGM Score57.38

P/CF (Annual)62.82x

Book Value / Share (Quarterly)$8.15

P/TBV (Annual)9.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)40.67%

Cash Flow / Share (Quarterly)$-0.70

Price vs S&P 500 (YTD)-27.22%

Gross Margin (TTM)98.90%

Net Profit Margin (TTM)-4.20%

EPS (TTM)$-0.37

10-Day Avg Trading Volume0.51M

EPS Excl Extra (TTM)$-0.37

Revenue Growth (5Y)67.77%

EPS (Annual)$-0.71

ROI (Annual)-4.59%

Gross Margin (Annual)98.73%

Net Profit Margin (5Y Avg)-114.48%

Cash / Share (Quarterly)$17.10

Revenue Growth QoQ (YoY)18.34%

ROA (Last FY)-3.33%

Revenue Growth TTM (YoY)20.95%

EBITD / Share (TTM)$-0.37

ROE (5Y Avg)-25.99%

Operating Margin (TTM)-5.24%

Cash Flow / Share (Annual)$-0.30

P/B Ratio3.62x

P/B Ratio (Quarterly)3.85x

Net Income / Employee (Annual)$-67,800

EV / Revenue (TTM)3.31x

Net Interest Coverage (TTM)-176.01x

ROA (TTM)-1.66%

EPS Growth QoQ (YoY)153.36%

EPS Incl Extra (Annual)$-0.71

Current Ratio (Annual)4.04x

Quick Ratio (Quarterly)4.15x

3-Month Avg Trading Volume0.50M

52-Week Price Return-12.32%

EV / Free Cash Flow (Annual)73.32x

Revenue / Employee (TTM)$822,100

Tangible BV / Share (Quarterly)$169.97

P/S Ratio (Annual)3.80x

Asset Turnover (Annual)0.37x

52-Week High$40.71

Operating Margin (5Y Avg)-119.14%

EPS Excl Extra (Annual)$-0.71

CapEx CAGR (5Y)7.17%

26-Week Price Return-7.23%

Quick Ratio (Annual)3.94x

13-Week Price Return-15.90%

Total Debt / Equity (Annual)1.03x

Current Ratio (Quarterly)4.47x

Enterprise Value$1.43B

Revenue / Share Growth (5Y)62.02%

Asset Turnover (TTM)0.40x

Revenue / Employee (Annual)$763,400

Inventory Turnover (Annual)0.83x

Pretax Margin (Annual)-4.77%

Cash / Share (Annual)$17.05

3-Month Return Std Dev30.13%

Net Income / Employee (TTM)$-34,500

ROE (Last FY)-9.32%

Net Interest Coverage (Annual)-12.65x

EPS Basic Excl Extra (Annual)$-0.71

P/FCF (TTM)100.26x

Receivables Turnover (TTM)5.22x

EV / Free Cash Flow (TTM)519.48x

Total Debt / Equity (Quarterly)0.94x

EPS Incl Extra (TTM)$-0.37

Receivables Turnover (Annual)5.84x

ROI (TTM)-2.28%

P/S Ratio (TTM)3.52x

Pretax Margin (5Y Avg)-121.73%

Revenue / Share (Annual)$7.95

Tangible BV / Share (Annual)$5.79

Forward P/E778.99x

Price vs S&P 500 (52W)-27.85%

Year-to-Date Return-15.30%

5-Day Price Return1.24%

EPS Normalized (Annual)$-0.71

ROA (5Y Avg)-14.14%

Net Profit Margin (Annual)-8.88%

Month-to-Date Return-2.94%

Cash Flow / Share (TTM)$-1.24

EBITD / Share (Annual)$-0.84

Operating Margin (Annual)-11.34%

LT Debt / Equity (Annual)1.03x

P/CF (TTM)204.86x

ROI (5Y Avg)-18.48%

LT Debt / Equity (Quarterly)0.94x

EPS Basic Excl Extra (TTM)$-0.37

P/TBV (Quarterly)6.45x

P/B Ratio (Annual)4.52x

Inventory Turnover (TTM)0.72x

Pretax Margin (TTM)-0.63%

Book Value / Share (Annual)$7.52

Price vs S&P 500 (13W)-18.59%

Beta0.82x

P/FCF (Annual)72.68x

Revenue / Share (TTM)$8.45

ROE (TTM)-4.54%

52-Week Low$27.50

vGradeD

gGradeB

mGradeB

vgmGradeC

IMCR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.02	-$0.02	-195.65%(-$0.04)
Q1 2026	May 6, 2026	-$0.26	$0.25	+196.46%(+$0.51)
Q4 2025	Feb 25, 2026	-$0.20	-$0.60	-195.96%(-$0.40)
Q3 2025	Nov 6, 2025	-$0.24	$0.00	+100.00%(+$0.24)
Q2 2025	Aug 7, 2025	-$0.21	-$0.20	+3.13%(+$0.01)

IMCR Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.09

4.05

Industry Peers — Biological Products(186)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	3.5x	20.9%	98.9%	—	$29.40
AMGNAmgen Inc	D	C	A	6.1x	9.1%	74.3%	2.9%	$432.49
GILDGilead Sciences Inc	C	B	A	6.4x	5.5%	79.6%	133.6%	$156.19
MRNAModerna, Inc. Common Stock	F	C	A	39.1x	-27.6%	36.4%	—	$218.01
ARGXargenx SE American Depositary Shares	D	A	B	6.6x	165.2%	89.8%	—	$819.14
RVMDRevolution Medicines, Inc. Common Stock	F	—	B	3296.2x	—	—	—	$177.96
BIIBBiogen Inc. Common Stock	C	D	A	3.4x	0.3%	74.0%	-18.8%	$232.65
BNTXBioNTech SE American Depositary Share	C	C	C	7.6x	-11.8%	79.2%	—	$87.71
EXELExelixis Inc	C	B	A	6.3x	9.2%	96.5%	31.1%	$62.23
HALOHalozyme Therapeutics, Inc.	D	B	A	8.3x	41.1%	82.4%	22.9%	$121.84
NBIXNeurocrine Biosciences Inc	C	B	B	4.1x	34.4%	98.0%	2.3%	$135.71
TECHBio-Techne Corp.	D	C	B	9.4x	-0.4%	66.2%	6.0%	$72.57
RGENRepligen Corp	F	C	A	14.2x	16.5%	53.8%	-4.9%	$175.42
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	—	—	—	—	$135.07
PCVXVaxcyte, Inc. Common Stock	—	—	B	—	—	—	—	$63.62
IBRXImmunityBio, Inc. Common Stock	F	A	A	58.7x	192.9%	99.3%	—	$9.18
QGENQIAGEN N.V.	C	C	B	4.5x	3.0%	62.5%	4.2%	$46.13
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	21.3x	22.6%	94.6%	—	$316.58
TWSTTwist Bioscience Corporation Common Stock	D	B	A	20.2x	19.2%	52.0%	—	$132.75
KYMRKymera Therapeutics, Inc. Common Stock	F	B	B	83.0x	134.8%	—	—	$104.78
IOVAIovance Biotherapeutics, Inc. Common Stock	D	B	A	19.0x	34.5%	48.4%	—	$13.62
IMVTImmunovant, Inc. Common Stock	—	—	C	—	—	—	—	$26.73
KODKodiak Sciences Inc Common Stock	—	—	A	—	—	—	—	$85.75
CGONCG Oncology, Inc. Common stock	F	A	B	851.8x	1030.3%	-85.2%	—	$59.85
SRRKScholar Rock Holding Corporation Common Stock	F	—	C	102.7x	—	—	—	$39.90
CRSPCRISPR Therapeutics AG	D	B	B	355.6x	-64.8%	—	—	$49.25
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	B	12.4x	50.1%	75.6%	—	$24.02
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	344.7x	23.9%	—	—	$16.28
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	5.5x	105.2%	93.3%	—	$68.07
DNLIDenali Therapeutics Inc. Common Stock	F	—	C	781.1x	—	—	—	$17.61
BEAMBeam Therapeutics Inc. Common Stock	D	B	C	15.5x	158.9%	—	—	$23.47
ADMAADMA Biologics, Inc.	C	C	B	4.7x	8.0%	64.7%	—	$10.68
VCELVericel Corporation	D	B	B	6.7x	22.9%	74.6%	38.9%	$40.13
BCRXBioCryst Pharmaceuticals Inc	B	A	B	2.1x	68.7%	97.8%	—	$7.79
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	33.9x	-15.1%	3.5%	—	$3.46
NVAXNovavax Inc	C	D	B	4.5x	-61.6%	79.2%	—	$11.26
ALVOAlvotech Ordinary Shares	D	D	B	3.9x	-12.1%	60.7%	—	$5.00
MESOMesoblast Limited American Depositary Shares	D	A	C	14.6x	599.2%	86.1%	—	$13.28
VIRVir Biotechnology, Inc. Common Stock	B	B	B	5.6x	1496.1%	100.0%	—	$9.96
MAZEMaze Therapeutics, Inc. Common Stock	—	A	B	—	700.0%	—	—	$27.53
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	C	—	—	—	—	$30.07
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	944.3x	550.0%	—	—	$89.83
TSHATaysha Gene Therapies, Inc. Common Stock	D	C	D	120.7x	-32.3%	—	—	$3.62
IMTXImmatics N.V. Ordinary Shares	C	C	C	21.5x	-68.0%	—	—	$6.73
REPLReplimune Group, Inc.	—	—	B	—	—	—	—	$10.86
VORVor Biopharma Inc. Common Stock	—	—	C	—	—	—	—	$18.03
MGTXMeiraGTx Holdings plc Ordinary Shares	C	A	C	2.2x	948.4%	98.0%	—	$9.28
SLBTSL Science Holding Limited Ordinary Shares	—	—	D	—	—	—	—	$1.53
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	C	—	—	—	—	$12.93
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	D	28.9x	-83.9%	—	—	$9.74
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	B	168.6x	-19.0%	—	—	$17.17

About Immunocore Holdings plc American Depositary Shares

Immunocore is a commercial-stage biotechnology company that markets KIMMTRAK for unresectable and metastatic uveal melanoma. The company leverages its proprietary ImmTAX platform to develop a pipeline of candidates across oncology, infectious disease, and autoimmune disorders, including Brenetafusp and other clinical and pre-clinical programs.